Public Policy Letters, Statements, Legal Briefs, & Other Responses

  • ACMG Comments to CMS Regarding NCD 90.2 and Medicare Coverage of NGS for Advanced Cancer
  • Group Sign-on Letter to CMS Requesting Extension of Comment Period Regarding NGS Coverage Reconsideration
  • Group Sign-on Letter to Congress Supporting the Medical Nutrition Equity Act (MNEA)
  • ACMG Letter Regarding Colorado Senate Bill 133 (2019) – Requesting Amendments
  • ACMG Letter Regarding Texas House Bill 2815 (2019) – Requesting Amendments
  • ACMG Letter Regarding Texas Senate Bill 754 (2019) – Requesting Amendments
  • ACMG Comments to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act Discussion Draft
  • ACMG Letter to Congress Regarding the Advancing Access to Precision Medicine Act
  • Group Sign-on Letter to CMS Requesting Revision of Interpretation of NCD for NGS for Advanced Cancer
  • ACMG Letter to Congress Concerning Legislation for Reimbursement of Genetic Counseling Services
  • ACMG Letter to Congress Concerning Legislation for Reimbursement of Genetic Counseling Services
  • ACMG Letter Regarding Pennsylvania House Bills 2618 and 2619 (2018) – Requesting Amendments